Q1 2026 Results
Ipsen will publish its sales results for the first quarter of 2026 on 23 April 2026.
An investor and analyst conference call will take place on the same day at 2:00 p.m. CET.
Period
recent search
Showing: 1 – 05 of 32 Financial Results
27 July 2023
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance
The performance in the first half of the year is reflected in today’s upgrade to our full-year guidance. We look forward to more milestones and further expansion of the pipeline over time through additional external-innovation transactions. I am confident, as…
27 April 2023
LinkedIn
Facebook
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
Paris (France), 27 April 2023
09 February 2023
LinkedIn
Ipsen presents strong full-year 2022 results and guidance for 2023
Paris (France), 9 February 2023
27 October 2022
LinkedIn
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
Paris (France), 27 October 2022
28 July 2022
LinkedIn
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:
Your dedicated contacts
Henry Wheeler
Vice President, Investor Relations
Khalid Deojee
Senior Manager, Investor Relations